Vida Ventures LLC 13D and 13G filings for Kinnate Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 2:59 pm Sale | 2024-09-30 | 13G | Kinnate Biopharma Inc. KNTE | Vida Ventures LLC | 0 0.000% | -2,207,772 (Position Closed) | Filing |
| 2023-02-13 4:21 pm Sale | 2022-12-31 | 13G | Kinnate Biopharma Inc. KNTE | Vida Ventures LLC | 2,207,772 5.000% | -539,661 (-19.64%) | Filing |
| 2022-02-10 5:17 pm Purchase | 2021-12-31 | 13G | Kinnate Biopharma Inc. KNTE | Vida Ventures LLC | 2,747,433 6.300% | 359 (+0.01%) | Filing |
| 2021-02-12 5:40 pm Purchase | 2020-12-31 | 13G | Kinnate Biopharma Inc. KNTE | Vida Ventures LLC | 2,747,074 6.300% | 2,747,074 (New Position) | Filing |